In vitro method for predicting the biocompatibility of medical implants

June 15, 2017

Researchers at the Universitat Jaume I (UJI), the University of the Basque Country (UPV-EHU) and the Centre for Cooperative Research in Biosciences (CIC bioGUNE) have patented a new in vitro method for predicting the biocompatibility of materials to be used in the manufacture of medical implants, such as joint and dental prostheses, valves and stents.

The patent is based on the detection of a group of proteins linked to the inflammatory reaction. In fact, researchers have identified a profile of protein markers, related to the immune response, that can be analysed in an isolated biological sample in vitro, and whose presence above a reference level is indicative of non-biocompatibility in vivo. "This methodology," explains the researcher Nuno Araújo, "will enable us to face the experiment in vivo with more security in the future, and to reduce the number of animals involved, while reducing time and costs."

The invention consists in an accelerated test of the biocompatibility of materials that makes it possible to discard those with poorer prospects of success during the in vitro phase, thus avoiding costly investments in unnecessary in vivo studies and facilitating a faster transfer of the to the clinical stage. It accelerates and significantly reduces the development of new implant materials and reduces the number of animals used for experimentation.

This methodology involves a robust correlation between the protein profile obtained in the in vitro tests and that acquired by means of in vivo trials, which are, by definition, more reliable. Thus, through the in vitro/in vivo correlation, determination and quantification of such markers in in vitro samples predicts the biocompatibility of biomaterials-implants, joint and dental prostheses or catheters, according to main researcher Julio Suay.

The technology is useful for the sectors of manufacturers of medical prostheses and for the producers of biomaterials, as well as for research groups of R & D centres that carry out in vitro and in vivo tests applied to the development of new materials. In the healthcare sector, it is particularly useful for patients who need an implant. In fact, with a simple blood test, detailed information could be obtained about whether the patient is likely to suffer complications in .

Explore further: Researchers increase the success rate of tooth implants

More information: Francisco Romero-Esparver et al. Proteome analysis of human serum proteins adsorbed onto different titanium surfaces used in dental implants, Biofouling (2016). DOI: 10.1080/08927014.2016.1259414

Related Stories

Researchers increase the success rate of tooth implants

April 29, 2013
Elderly or people with osteoporosis, smokers, diabetics or people who have had cancer are sometimes not eligible to receive dental implants as their bones are unable to correctly integrate the new prostheses which replace ...

Scientists increase the success rate of tooth implants

January 21, 2013
Elderly or people with osteoporosis, smokers, diabetics or people who have had cancer are sometimes not eligible to receive dental implants as their bones are unable to correctly integrate the new prostheses which replace ...

A novel animal model for analysing human natural killer cell functions in vivo

March 27, 2017
Natural killer (NK) cells which belong in innate immunity, play an important role for defense against invading pathogens and microbes. NK cells make up around 5-20% of the white blood cells circulating in the bloodstream ...

Stem cells may significantly improve tendon healing by regulating inflammation

May 23, 2017
New research published online in The FASEB Journal suggests that tendon stem (TSCs) may be able to significantly improve tendon healing by regulating inflammation, which contributes to scar-like tendon healing and chronic ...

Recommended for you

Outdoor light at night linked with increased breast cancer risk in women

August 17, 2017
Women who live in areas with higher levels of outdoor light at night may be at higher risk for breast cancer than those living in areas with lower levels, according to a large long-term study from Harvard T.H. Chan School ...

Scientists develop novel immunotherapy technology for prostate cancer

August 17, 2017
A study led by scientists at The Wistar Institute describes a novel immunotherapeutic strategy for the treatment of cancer based on the use of synthetic DNA to directly encode protective antibodies against a cancer specific ...

Toxic formaldehyde is produced inside our own cells, scientists discover

August 16, 2017
New research has revealed that some of the toxin formaldehyde in our bodies does not come from our environment - it is a by-product of an essential reaction inside our own cells. This could provide new targets for developing ...

Cell cycle-blocking drugs can shrink tumors by enlisting immune system in attack on cancer

August 16, 2017
In the brief time that drugs known as CDK4/6 inhibitors have been approved for the treatment of metastatic breast cancer, doctors have made a startling observation: in certain patients, the drugs—designed to halt cancer ...

Researchers find 'switch' that turns on immune cells' tumor-killing ability

August 16, 2017
Molecular biologists led by Leonid Pobezinsky and his wife and research collaborator Elena Pobezinskaya at the University of Massachusetts Amherst have published results that for the first time show how a microRNA molecule ...

Popular immunotherapy target turns out to have a surprising buddy

August 16, 2017
The majority of current cancer immunotherapies focus on PD-L1. This well studied protein turns out to be controlled by a partner, CMTM6, a previously unexplored molecule that is now suddenly also a potential therapeutic target. ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.